Cargando…
Cardiovascular effects of hormone therapy for prostate cancer
Androgen deprivation therapy (ADT) has been the mainstay of treatment for advanced prostate cancer for decades, and has been shown to control disease and improve symptoms. In addition, for men with high-risk localized or locally advanced prostate cancer, short-course ADT in combination with radiothe...
Autores principales: | Lester, Jason F, Mason, Malcolm D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516188/ https://www.ncbi.nlm.nih.gov/pubmed/26229507 http://dx.doi.org/10.2147/DHPS.S50549 |
Ejemplares similares
-
Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy
por: Ryan, Charles J., et al.
Publicado: (2020) -
The side effects of hormonal therapy at the patients with prostate cancer
por: Ziółkowska, Ewa, et al.
Publicado: (2013) -
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015) -
The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
por: Miura, Yuji, et al.
Publicado: (2019) -
Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)